Correspondence

Response to the ACMD's report on remimazolam (Byfavo)

The government responds to a report by the Advisory Council on the Misuse of Drugs (ACMD) regarding the classification and schedule of remimazolam (Byfavo).

• From: Home Office, Advisory Council on the Misuse of Drugs and The Rt Hon Chris Philp MP
• Published: 2 March 2023

This was published under the 2022 to 2024 Sunak Conservative government

Documents

Government response to ACMD advice on remimazolam (accessible)

HTML

Government response to ACMD advice on remimazolam

PDF, 109 KB, 1 page

Details

A letter from the Minister of State for Crime, Policing and Fire to the Advisory Council on the Misuse of Drugs (ACMD), responding to the ACMD’s advice in December 2022 regarding the classification and schedule of remimazolam (Byfavo).

Published 2 March 2023